(Q44023176)

English

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

scientific article

Statements

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). (English)
Montserrat Rue
Emily Blood
Lynne S Kaminer
David H Vesole
Philip R Greipp
1 October 2004
2047-2055

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit